Q2 2025 saw net sales rise to SEK 5.4m, but operating losses deepened to SEK -27.2m, with negative value changes in securities. Ivisys drove all sales, while Flyttsmart and Lifesum showed strong growth amid challenging market conditions.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.